Observational studyArchives of gynecology and obstetrics2026
High prevalence of magnesium supplementation during pregnancy: results from the LIFE Child study.
Observational study in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02550236 (Prospective Population-based Childhood Cohort Study in the Leipzig Area Investigating Genetic, Environmental, and Metabolic Factors and Their Association With the Development of Civilization Diseases), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prospective Population-based Childhood Cohort Study in the Leipzig Area Investigating Genetic, Environmental, and Metabolic Factors and Their Association With the Development of Civilization Diseases
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe examined the prevalence of magnesium supplementation among pregnant women in Germany and assessed whether risk factors for preterm birth might be associated with magnesium use. We explored the association between magnesium supplementation and pregnancy duration .
methodsThe LIFE Child Study (Leipzig, Germany) recruited pregnant women and collected data in the 24
resultsDuring their current pregnancy, 60.0% (647/1078) of the women supplemented mono-magnesium, and 70.8% (763/1078) supplemented magnesium through mono- and/or combination preparations (overall magnesium). In 215 women, information on physicians' recommendations/prescriptions was collected: In 84.2% (181/215) of those women, a physician prescribed (104/215, 48.4%) or recommended (77/215, 35.8%) the mono-magnesium supplement. Increasing age was positively associated with magnesium supplementation with overall magnesium use increasing from 57.8% at age 20 years to 84.3% at age 45. Women with medium (OR 2.93; 95% CI 1.20-7.37) or high SES (OR 3.82; 95% CI 1.54-9.77) were more likely to supplement overall magnesium than women with low SES. Mono-magnesium supplementation was more likely in women with premature contractions (OR 2.97; 95% CI 1.36-7.47) with a still positive but not significant effect for overall magnesium (OR = 1.78, 95% CI 0.81-4.49). Magnesium supplementation did not affect pregnancy duration.
conclusionMagnesium supplementation during pregnancy is widespread. Increasing age, higher SES, and premature contractions seem to have the potential to influence magnesium supplementation during pregnancy.
trial registrationLIFE Child is registered under the trial number: NCT02550236.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.